Syra Health Corp.
SYRA
$0.1043
-$0.0228-17.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.81% | 69.97% | 3.93% | -45.39% | -180.84% |
| Total Depreciation and Amortization | 226.52% | 20.33% | 12.07% | 1.39% | 332.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4,090.91% | -90.06% | 0.61% | 132.42% | -262.88% |
| Change in Net Operating Assets | 491.92% | 70.21% | -134.32% | 180.97% | -1,095.92% |
| Cash from Operations | 48.05% | 72.51% | -87.75% | 54.43% | -375.76% |
| Capital Expenditure | -- | 100.00% | 1.79% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 1.79% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 14.91% | 23.89% | -56.93% | 90.48% | -32.95% |
| Issuance of Common Stock | -100.00% | -- | -100.00% | -84.06% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 321.80% |
| Cash from Financing | -105.76% | 1,224.93% | -117.64% | -84.77% | 1,330.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -127.39% | 167.11% | -3,804.04% | -101.29% | 17,828.80% |